LearnGlossaryMarketStocksSuperinvestorsSign in

RDNT

RadNet, Inc.

Healthcare · $5.6B market cap

Verdict

We can't put a fair value on RDNT right now. Its earnings are too small compared with its share price for an earnings-based value to mean anything.

Business quality

2 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth-6.9% a year✗
Equity per share growth34.8% a year✓
Sales growth8.4% a year✗
Free cash flow growth11.8% a year✓
Return on invested capital2.6%✗

Follow RDNT

Track it on your watchlist and see the full analysis. Free.

Create a free account

Superinvestors

2 of the investors we track hold RDNT. In Q2 2026, 1 added. Who we track

First Eagle Investment Management

First Eagle Investment Management · as of Q2 2026

$12.0M

195,036 shares

Mairs & Power Funds

Mairs & Power Funds · as of Q2 2026

$8.2M

133,116 shares

Moves in Q2 2026

Added: First Eagle Investment Management

About RadNet, Inc.

RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with…

Medical - Diagnostics & Research

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works